Skip to main content

Advertisement

Table 2 Specific clinical characteristics of studied subjects

From: Role of disturbed fatty acids metabolism in the pathophysiology of diabetic erectile dysfunction

Characteristics Patients with VED (n = 72) Patients w/o ED (n = 78) Controls (n = 88)
Inflammatory Cytokines
 IL-6 (pg/mL) 0.86 ± 0.5** 0.51 ± 0.2 0.44 ± 0.3
 TNF-α (pg/mL) 3.3 ± 2.9** 2.9 ± 1.9** 1.43 ± 1.2
Lipid peroxidation
 MDA (μM) 23.9 ± 4.5** 18.7 ± 5.3 17.11 ± 5.9
 Conjugated diene (μM) 139.16 ± 68.4 141.76 ± 34.5 122.4 ± 55.9
Serum Hormones
 FSH (mIU/mL) 7.22 ± 4.9 6.83 ± 2.6 6.32 ± 2.4
 LH (mIU/mL) 5.67 ± 3.4 6.14 ± 3.6 6.07 ± 2.1
 PRL (ng/mL) 12.16 ± 5.1 12.83 ± 4.4 11.19 ± 2.9
 Testosterone (ng/mL) 5.35 ± 1.5 6.12 ± 2.8 5.89 ± 2.1
 FT4 (pmoL/L) 13.92 ± 1.5 12.53 ± 2.6 13.64 ± 2.3
 hsTSH (μIU/mL) 1.95 ± 0.9 1.76 ± 0.7 1.83 ± 0.9
  1. Values are given as mean ± standard error
  2. NO nitric oxide, TNF-α tumor necrosis factor alpha, IL-6 interleukine 6, MDA malondialdehyde, FSH follicle-stimulating hormone, LH luteinizing hormone, PRL prolactin, FT4 Free thyroxine 4, hsTSH high sensitive thyroid-stimulating hormone, w/o without
  3. *P < 0.05 and **P < 0.001 compared to controls